Skip to main content
. 2020 Aug 18;13(8):1257–1265. doi: 10.18240/ijo.2020.08.12

Figure 1. OCTA images and B-scan images in an affected right eye.

Figure 1

Female, 47 years old. A: One day before laser: A1 foveal avascular zone area (FAZ), 1.34 mm2; superficial parafoveal vessel density (sPVD), 38.4%; deep parafoveal vessel density (dPVD), 40.7%, A2 choriocapillary flow area (ChF), 1.71 mm2, A3 capillary density inside disc (CDD), 52.1%; peripapillary capillary density (PCD), 52.3%, A4 and A5 central macular thickness (CMT), 344.72 µm; subfoveal choroidal thickness (ChT), 286.42 µm. B: One day after laser: B1 FAZ, 1.38 mm2; sPVD, 41.5%; dPVD, 42.8%, B2 ChF, 1.64 mm2, B3 CDD, 51.1%; PCD, 51.4%, B4 and B5 CMT, 349.63 µm; ChT, 292.35 µm. C: One week after laser: C1 FAZ, 1.42 mm2; sPVD, 39.2%; dPVD, 41.8%, C2 ChF, 1.75 mm2, C3 CDD, 50.5%; PCD, 50.4%, C4 and C5 CMT, 332.82 µm; ChT, 281.49 µm. D: One month after laser: D1 FAZ, 1.53 mm2; sPVD, 38.7%; dPVD, 41.2%, D2 ChF, 1.46 mm2, D3 CDD, 49.3%; PCD, 50.6%, D4 and D5 CMT, 302.54 µm; ChT, 270.47 µm. E: Two months after laser, the patient had an additional follow-up because of decreased vision. Another SML treatment was performed. E1 FAZ, 1.58 mm2; sPVD, 38.4%; dPVD, 37.9%, E2 ChF, 1.46 mm2, E3 CDD, 49.7%; PCD, 51.2%, E4 and E5 CMT, 397.32 µm; ChT, 272.12 µm. F: Three months after laser: F1 FAZ, 1.60 mm2; sPVD, 37.5%; dPVD, 40.3%, F2 ChF, 1.45 mm2, F3 CDD, 49.5%; PCD, 50.1%, F4 and F5 CMT, 287.63 µm; ChT, 272.43 µm. G: Six months after laser: G1 FAZ, 1.69 mm2; sPVD, 37.2%; dPVD, 39.8%, G2 ChF, 1.44 mm2, G3 CDD, 47.4%; PCD, 48.8%, G4 and G5 CMT, 256.42 µm; ChT, 267.15 µm.